Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Walter

Showing results (811-820 of 851) with videos related to

Pageof 86
Sort By:
Nature Communications|August 9, 2018
Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide bindingLucy C Walters, Karl Harlos, Simon Brackenridge, et al.
Science Advances|June 21, 2023
Accelerating drug target inhibitor discovery with a deep generative foundation modelVijil Chenthamarakshan, Samuel C Hoffman, C David Owen, et al.
Nature Communications|November 14, 2018
Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide bindingLucy C Walters, Karl Harlos, Simon Brackenridge, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2009
Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimeticsNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2009
Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokineticsNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
The Journal of Frailty & Aging|June 26, 2019
Proceedings of the Canadian Frailty Network Workshop: Identifying Biomarkers of Frailty to Support Frailty Risk Assessment, Diagnosis and Prognosis. Toronto, January 15, 2018J Muscedere, P M Kim, J Afilalo, et al.
Acta Crystallographica. Section D, Biological Crystallography|June 3, 2005
A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimizationThomas S Walter, Jonathan M Diprose, Chris J Mayo, et al.
Nature Communications|September 7, 2024
Molecular epidemiology and evolutionary characteristics of dengue virus 2 in East AfricaSindiso Nyathi, Izabela M Rezende, Katharine S Walter, et al.
Journal of Medicinal Chemistry|May 7, 2008
Second generation of hydroxyethylamine BACE-1 inhibitors: optimizing potency and oral bioavailabilityNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
Blood|November 7, 2015
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignanciesHarriet S Walter, Simon A Rule, Martin J S Dyer, et al.
Pageof 86

Showing results (811-820 of 851) with videos related to

Sort By:
Pageof 86
Nature Communications|August 9, 2018
Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide bindingLucy C Walters, Karl Harlos, Simon Brackenridge, et al.
Science Advances|June 21, 2023
Accelerating drug target inhibitor discovery with a deep generative foundation modelVijil Chenthamarakshan, Samuel C Hoffman, C David Owen, et al.
Nature Communications|November 14, 2018
Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide bindingLucy C Walters, Karl Harlos, Simon Brackenridge, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2009
Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimeticsNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2009
Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokineticsNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
The Journal of Frailty & Aging|June 26, 2019
Proceedings of the Canadian Frailty Network Workshop: Identifying Biomarkers of Frailty to Support Frailty Risk Assessment, Diagnosis and Prognosis. Toronto, January 15, 2018J Muscedere, P M Kim, J Afilalo, et al.
Acta Crystallographica. Section D, Biological Crystallography|June 3, 2005
A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimizationThomas S Walter, Jonathan M Diprose, Chris J Mayo, et al.
Nature Communications|September 7, 2024
Molecular epidemiology and evolutionary characteristics of dengue virus 2 in East AfricaSindiso Nyathi, Izabela M Rezende, Katharine S Walter, et al.
Journal of Medicinal Chemistry|May 7, 2008
Second generation of hydroxyethylamine BACE-1 inhibitors: optimizing potency and oral bioavailabilityNicolas Charrier, Brian Clarke, Leanne Cutler, et al.
Blood|November 7, 2015
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignanciesHarriet S Walter, Simon A Rule, Martin J S Dyer, et al.
Pageof 86